MetLife Investment Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$58.4K Sell
2,205
-4,331
-66% -$115K ﹤0.01% 2675
2025
Q1
$158K Sell
6,536
-14
-0.2% -$338 ﹤0.01% 2316
2024
Q4
$264K Sell
6,550
-79
-1% -$3.18K ﹤0.01% 2158
2024
Q3
$420K Sell
6,629
-130
-2% -$8.23K ﹤0.01% 1875
2024
Q2
$358K Sell
6,759
-45,439
-87% -$2.41M ﹤0.01% 1912
2024
Q1
$4.28M Buy
52,198
+1,501
+3% +$123K 0.03% 577
2023
Q4
$943K Hold
50,697
0.01% 1326
2023
Q3
$561K Hold
50,697
﹤0.01% 1556
2023
Q2
$822K Buy
+50,697
New +$822K 0.01% 1377
2022
Q2
Sell
-7,040
Closed -$21.1K 2908
2022
Q1
$21.1K Sell
7,040
-19,437
-73% -$58.3K ﹤0.01% 2708
2021
Q4
$122K Buy
26,477
+11,454
+76% +$52.7K ﹤0.01% 2332
2021
Q3
$94.3K Sell
15,023
-12,499
-45% -$78.5K ﹤0.01% 2464
2021
Q2
$165K Buy
27,522
+18,376
+201% +$110K ﹤0.01% 2270
2021
Q1
$57.8K Sell
9,146
-20,668
-69% -$131K ﹤0.01% 2279
2020
Q4
$168K Buy
29,814
+1,212
+4% +$6.82K ﹤0.01% 2074
2020
Q3
$166K Hold
28,602
﹤0.01% 1970
2020
Q2
$206K Hold
28,602
﹤0.01% 1887
2020
Q1
$134K Hold
28,602
﹤0.01% 1920
2019
Q4
$229K Hold
28,602
﹤0.01% 1906
2019
Q3
$197K Hold
28,602
﹤0.01% 1958
2019
Q2
$237K Hold
28,602
﹤0.01% 1927
2019
Q1
$284K Hold
28,602
﹤0.01% 1779
2018
Q4
$219K Buy
28,602
+6,905
+32% +$52.8K ﹤0.01% 1858
2018
Q3
$378K Hold
21,697
﹤0.01% 1713
2018
Q2
$206K Buy
+21,697
New +$206K ﹤0.01% 1908